Confusions galore in the erectile dysfunction therapeutic drug market, with the constant condemnations and denouncements among the major players in the league. To put it in simple terms, the verbal war is doing no good to a good number of men, hit below the belt by sexual dysfunction. They don’t give a heck, if Cialis sales are on an all time high or Bob Dole is endorsing Viagra; they only want their erection back, come what may. But, with the market ripe for the picking, the drug lords like Pfizer, Lilly Icos and Bayer are swooping down for the kill, zealously guarding their own territories, and eying for more.
The companies that produce erectile dysfunction drugs have baffled and befuddled the patients to no ends with their unethical and inept handling of the whole issue. Different companies have manufactured various ED drugs of similar nature, making it difficult for a patient to choose with a number of equally productive and effective options available. And with the different drug companies trying to grab your attention with their magic drugs, you get all the more confused that you start contemplating on your choice.
Viagra, Cialis and Levitra are no appetizers on a menu that you can make an order to suit your taste, at your own sweet will; they are prescription drugs that matter a lot to your sexuality. Sometimes, this whole issue of erectile dysfunction drugs is mind-boggling. We down a shake or a diet coke without taking anyone’s opinion on the choice of the label; it doesn’t matter if we take diet Coke or Pepsi as long as we quench our thirst. Why don’t we view erectile dysfunction, the way we look at hunger or thirst? That way, we won’t get into a jam or run into further confusions in deciding over Viagra, Levitra or Cialis. But sadly, this is not so, with the companies drawing the dividing lines between themselves in a selfish effort to have a larger share of the pie.
The astronomical sum that goes down the drain through the ads and promos in the all out attempts of the companies to outwit and outdo the rest of the players would be an accountant’s delight. The Viagra vs. Cialis vs. Levitra advertising war is unparalleled, a rivalry unmatched even by the traditional creative duels between Pepsi and Coke. They are leaving no stone unturned to prove the virility and strength of their erections. It’s not a David and Goliath duel; it’s a war of the pharmaceutical Goliaths.
Every Tom, Dick and Harry sells genuine, authentic, discounted, and cheap versions of Viagra, Cialis and Levitra in cyber space, defying common logic and adding to the confusion. It is nothing less than the height of erectile confusion. We always come across Cialis of the best quality or Levitra of the cheapest range after we have ordered Viagra of the finest quality at the fairest deal. Every time we read a press release on Viagra, we are all for Viagra till we get carried by the latest study on Levitra or we get bowled over by the ground breaking research on Cialis. The confusion sees no end.
Connoisseurs in the field say that it is best to talk to a physician, if one suffers from symptoms of erectile dysfunction, to get a proper diagnosis and treatment. That way we can steer clear of the confusion, with the tricky proposition of choosing the right erectile dysfunction drug resting solely on the shoulders of a physician. But, I, for one would still be skeptical, as pharmaceutical companies are hand in glove with the registered physicians. Doctors practice what medical reps preach; there is an unholy alliance between them.
Viagra occupies a special place in the heart of erectile dysfunction patients, with the “We are the Champions” ad (a line from the famous Queen’s song) still fresh in their minds, though the other Johnny-come-lately competitors are vying for that spot. But the choice is yours, as it your erection you are worried about as I do mine.
Naorem is a freelancer who writes on diverse aspects of male sexual health. Visit http://www.viagrathunder.com , http://www.viagracare.com and http://www.buy-viagra-with-us.com for more tidbits on the issue.